324 related items for PubMed ID: 23426829
1. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
J Pediatr Endocrinol Metab; 2012; 25(9-10):977-81. PubMed ID: 23426829
[Abstract] [Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
3. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
[Abstract] [Full Text] [Related]
4. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
5. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
6. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009 Mar; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
7. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP, Winter A, Stolecke H.
Klin Padiatr; 1997 Mar; 209(2):71-7. PubMed ID: 9113619
[Abstract] [Full Text] [Related]
8. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[Abstract] [Full Text] [Related]
9. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Jul; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
10. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
11. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
Patel L, Chandrashekhar SR, Gemmell I, O'Shea E, Jones J, Banerjee I, Amin R, Clayton P.
Horm Res Paediatr; 2011 Nov; 75(3):206-12. PubMed ID: 20962509
[Abstract] [Full Text] [Related]
12. [A clinical study of congenital adrenal hyperplasia].
Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
[Abstract] [Full Text] [Related]
13. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
Sarafoglou K, Addo OY, Turcotte L, Otten N, Wickremasinghe A, Pittock S, Kyllo J, Lteif AN, Himes JH, Miller BS.
J Pediatr; 2014 May; 164(5):1141-1146.e1. PubMed ID: 24560184
[Abstract] [Full Text] [Related]
14. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
[Abstract] [Full Text] [Related]
15. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Dörr HG.
Horm Res; 2007 May; 68 Suppl 5():93-9. PubMed ID: 18174719
[Abstract] [Full Text] [Related]
16. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
Charmandari E, Hindmarsh PC, Johnston A, Brook CG.
J Clin Endocrinol Metab; 2001 Jun; 86(6):2701-8. PubMed ID: 11397874
[Abstract] [Full Text] [Related]
17. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
18. Growth and development in children with classic congenital adrenal hyperplasia.
Bonfig W.
Curr Opin Endocrinol Diabetes Obes; 2017 Feb 25; 24(1):39-42. PubMed ID: 27898585
[Abstract] [Full Text] [Related]
19. [Treatment of hypertensive forms of congenital adrenal hyperplasia].
Turpin G, Heshmati HM, Jambart S, de Gennes JL.
Ann Med Interne (Paris); 1983 Feb 25; 134(3):256-8. PubMed ID: 6605107
[Abstract] [Full Text] [Related]
20. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
J Pediatr Endocrinol Metab; 2006 Mar 25; 19(3):245-51. PubMed ID: 16607925
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
